title: Erythroid Kruppel-like factor (EKLF) is recruited to the gamma-globin gene promoter as a co-activator and is required for gamma-globin gene induction by short-chain fatty acid derivatives.
abstract: OBJECTIVE
  The erythroid Kruppel-like factor (EKLF) is an essential transcription factor for beta-type globin gene switching, and specifically activates transcription of the adult beta-globin gene promoter. We sought to determine if EKLF is also required for activation of the gamma-globin gene by short-chain fatty acid (SCFA) derivatives, which are now entering clinical trials.
  
  
  METHODS
  The functional and physical interaction of EKLF and co-regulatory molecules with the endogenous human globin gene promoters was studied in primary human erythroid progenitors and cell lines, using chromatin immunoprecipitation (ChIP) assays and genetic manipulation of the levels of EKLF and co-regulators.
  
  
  CONCLUSIONS
  Knockdown of EKLF prevents SCFA-induced expression of the gamma-globin promoter in a stably expressed microLCRbeta(pr)R(luc) (A)gamma(pr)F(luc) cassette, and prevents induction of the endogenous gamma-globin gene in primary human erythroid progenitors. EKLF is actively recruited to endogenous gamma-globin gene promoters after exposure of primary human erythroid progenitors, and murine hematopoietic cell lines, to SCFA derivatives. The core ATPase BRG1 subunit of the human SWI/WNF complex, a ubiquitous multimeric complex that regulates gene expression by remodeling nucleosomal structure, is also required for gamma-globin gene induction by SCFA derivatives. BRG1 is actively recruited to the endogenous gamma-globin promoter of primary human erythroid progenitors by exposure to SCFA derivatives, and this recruitment is dependent upon the presence of EKLF. These findings demonstrate that EKLF, and the co-activator BRG1, previously demonstrated to be required for definitive or adult erythropoietic patterns of globin gene expression, are co-opted by SCFA derivatives to activate the fetal globin genes.
authors.affiliation: Cancer Center, Boston University School of Medicine, Boston, MA 02118, USA.
authors.forename: Susan P
authors.initials: SP
authors.lastname: Perrine
authors.forename: Rishikesh
authors.initials: R
authors.lastname: Mankidy
authors.forename: Michael S
authors.initials: MS
authors.lastname: Boosalis
authors.forename: James J
authors.initials: JJ
authors.lastname: Bieker
authors.forename: Douglas V
authors.initials: DV
authors.lastname: Faller
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D004265:DNA Helicases / Q000502:physiology; D015672:Erythroid Precursor Cells / Q000378:metabolism; D005232:Fatty Acids, Volatile / Q000502:physiology*; D005319:Fetal Hemoglobin; D006801:Humans; D051741:Kruppel-Like Transcription Factors / Q000378:metabolism* / Q000502:physiology; D051379:Mice; D009687:Nuclear Proteins / Q000502:physiology; D011401:Promoter Regions, Genetic; D021381:Protein Transport; D014157:Transcription Factors / Q000502:physiology; D015533:Transcriptional Activation; D055545:gamma-Globins / Q000235:genetics*
chemical_list: D005232:Fatty Acids, Volatile; D051741:Kruppel-Like Transcription Factors; D009687:Nuclear Proteins; D014157:Transcription Factors; C080774:erythroid Kruppel-like factor; D055545:gamma-Globins; D005319:Fetal Hemoglobin; C084108:SMARCA4 protein, human; D004265:DNA Helicases